Blackstone sells Anthos to Novartis for up to $3.1bn

Anthos was founded by Blackstone Life Sciences and Novartis in 2019.

11 February 2025•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.